Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 275

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

Open access
Saini, Sharanjot, Majid, Shahana, Yamamura, Soichiro, Tabatabai, Laura, Suh, Seong O., Shahryari, Varahram, Chen, Yi, Deng, Guoren, Tanaka, Yuichiro, Dahiya, Rajvir·2011·Clinical Cancer Research

Abstract

Purpose: Advanced metastatic prostate cancer (PCa) is a fatal disease, with only palliative therapeutic options. Though almost 80% of cases of metastatic PCa present bone metastasis, our current understanding of the molecular mechanisms that govern this metastatic dissemination remains fragmentary. The main objective of the present study was to identify microRNA (miRNA) genes that regulate metastatic PCa. Experimental Design: miRNA expression profiling was done in human prostate cell lines to identify dysregulated miRNA components of advanced PCa. miR-203 expression was assessed in prostate carcinoma cell lines and clinical specimens by real-time PCR and in situ hybridization. To assess the biological significance of miR-203, miR-203 was reexpressed in bone metastatic PCa cell lines followed by in vitro and in vivo functional assays. Results: miR-203 expression is specifically attenuated in bone metastatic PCa suggesting a fundamental antimetastatic role for this miRNA. Reintroduction of miR-203 in bone metastatic PCa cell lines suppresses metastasis via inhibition of several critical steps of the metastatic cascade including epithelial-mesenchymal transition, invasion, and motility. Ectopic miR-203 significantly attenuated the development of metastasis in a bone metastatic model of PCa. Importantly, miR-203 regulates a cohort of pro-metastatic genes including ZEB2, Bmi, survivin, and bone-specific effectors including Runx2, a master regulator of bone metastasis. Conclusions: miR-203 is an “antimetastatic” miRNA in PCa that acts at multiple steps of the PCa metastatic cascade via repression of a cohort of prometastatic targets. miR-203 may be an attractive target for therapeutic intervention in advanced PCa. Clin Cancer Res; 17(16); 5287–98. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-10-2619

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 275

Metadata

Authors
Saini, S., Majid, S., Yamamura, S., Tabatabai, L., Suh, S. O., Shahryari, V., Chen, Y., Deng, G., Tanaka, Y., & Dahiya, R.
Venue
Clinical Cancer Research
Published
2011-08-14
Volume
17
Issue
16
Pages
5287-5298
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2167290557
Cited by
275
References
43
FWCI
7.41
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-2619
The paper
Saini, S., Majid, S., Yamamura, S., Tabatabai, L., Suh, S. O., Shahryari, V., Chen, Y., Deng, G., Tanaka, Y., & Dahiya, R. (2011). Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-2619

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.